Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months

Conditions: Healthy Population Interventions: Biological: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Zhifei Lvzhu); Biological: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Walvax); Biological: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Olymvax) Sponsors: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials